Literature DB >> 1449243

Effectiveness of botulinum toxin administered to abolish acquired nystagmus.

R J Leigh1, R L Tomsak, M P Grant, B F Remler, S S Yaniglos, L Lystad, L F Dell'Osso.   

Abstract

We injected botulinum toxin into the horizontal rectus muscles of the right eyes of 2 patients who had acquired pendular nystagmus with horizontal, vertical, and torsional components. This treatment successfully abolished the horizontal component of the nystagmus in the injected eye in both patients for approximately 2 months. Both patients showed a small but measurable improvement of vision in the injected eye that may have been limited by coexistent disease of the visual pathways. The vertical and torsional components of the nystagmus persisted in both patients. In 1 patient, the horizontal component of nystagmus in the noninjected eye increased; we ascribe this finding to plastic-adaptive changes in response to paresis caused by the botulinum toxin. Such plastic-adaptive changes and direct side effects of the injections--such as diplopia and ptosis--may limit the effectiveness of botulinum toxin in the treatment of acquired nystagmus. Neither patient elected to repeat the botulinum treatment.

Entities:  

Keywords:  NASA Discipline Neuroscience; Non-NASA Center

Mesh:

Substances:

Year:  1992        PMID: 1449243     DOI: 10.1002/ana.410320506

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Medical treatment of nystagmus and its visual consequences.

Authors:  John S Stahl; Gordon T Plant; R John Leigh
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 5.344

2.  Treatment of nystagmus.

Authors:  Matthew J Thurtell; R John Leigh
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

Review 3.  What we know about the generation of nystagmus and other ocular oscillations: are we closer to identifying therapeutic targets?

Authors:  Rebecca Jane McLean; Irene Gottlob; Frank Antony Proudlock
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

4.  Current treatment of vestibular, ocular motor disorders and nystagmus.

Authors:  Michael Strupp; Thomas Brandt
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

5.  Reduction of ocular muscle power by splitting of the rectus muscle I: biomechanics.

Authors:  T Haslwanter; R Hoerantner; S Priglinger
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 6.  [Rare tremor syndromes].

Authors:  J S Becktepe; F Goevert; G Deuschl
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

7.  Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin.

Authors:  Michaela Starck; Holger Albrecht; Walter Pöllmann; Marianne Dieterich; Andreas Straube
Journal:  J Neurol       Date:  2009-09-13       Impact factor: 4.849

Review 8.  [New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders].

Authors:  T Henze; W Feneberg; P Flachenecker; D Seidel; H Albrecht; M Starck; S G Meuth
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

9.  Treatment of Nystagmus in Brainstem Cavernous Malformation with Botulinum Toxin.

Authors:  Yi-Ren Chen; Douglas Fredrick; Gary K Steinberg; Yaping J Liao
Journal:  Cureus       Date:  2016-04-01

10.  The Use of Botulinum Toxin in a Case of Acquired Periodic Alternating Nystagmus.

Authors:  Nadia Venturi; Gillian Adams; Maria Theodorou
Journal:  Br Ir Orthopt J       Date:  2021-04-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.